Key result
IVUS guidance for covered stents is linked to ~96% lower odds of TVR.
Why the study?
Data are limited regarding the specific role of intravascular ultrasound in evaluating and guiding management after coronary artery perforation occurs during percutaneous coronary intervention and whether this approach improves clinical outcomes.
Does intravascular ultrasound (IVUS)-guided covered stent optimization reduce target vessel revascularization in patients experiencing coronary artery perforation during percutaneous coronary intervention?
Cohort (n=127)
No
Does intravascular ultrasound (IVUS)-guided covered stent optimization reduce target vessel revascularization in patients experiencing coronary artery perforation during percutaneous coronary intervention?
Using intravascular ultrasound to guide covered stent optimization after coronary artery perforation is associated with a significantly lower rate of long-term target vessel revascularization compared to angiographic guidance alone.
Answers are grounded in this paper and cite their sources.
May support IVUS consideration in covered stent cases; leaves open need for randomized confirmation before practice change.
Background Coronary artery perforation (CAP) during percutaneous coronary intervention carries significant morbidity and mortality; however, data are limited regarding the specific role of intravascular ultrasound (IVUS) in evaluating and guiding management after CAP occurs and whether this approach improves clinical outcomes. Methods This study consisted of a retrospective analysis of all patients who underwent percutaneous coronary intervention and experienced CAP treated with covered stents at a single tertiary care hospital between December 2014 and January 2024. The primary outcome was target vessel revascularization (TVR). Secondary outcomes included mortality, myocardial infarction, in-stent restenosis, and emergency cardiac surgery. Multivariable logistic regression was used to assess the association between IVUS and outcomes. Results Between 2014 and January 2024, 127 cases of CAP treated using covered stents were identified. Of these, 34 patients (26.8%) underwent IVUS-guided covered stent optimization, whereas 93 patients (73.2%) did not undergo IVUS. Patients in the IVUS group were older (75.1 ± 8.4 vs 61.0 ± 10.3 years; P < .001) and predominantly women (55.9% vs 31.2%; P = .020). The IVUS was more frequently used for left anterior descending artery perforations (64.7% vs 36.6%; P = .009). IVUS was associated with a reduced risk of TVR during an average follow-up of 60.3 months (adjusted odds ratio, 0.04; 95% CI, 0.02-0.56; P = .031). Other outcomes, including mortality and repeat myocardial infarction, were similar between the 2 groups. Conclusions The use of IVUS in patients requiring covered stents for CAP treatment, despite higher procedural complexity and a higher prevalence of severe perforations, was associated with significantly reduced TVR. This suggests a potential role for IVUS in improving clinical outcomes following CAP.
No takes yet. Share an insight, caveat, or question.
Abdelhai et al. (2025) conducted a cohort in Coronary artery perforation during percutaneous coronary intervention treated with covered stents (n=127). Intravascular ultrasound (IVUS)-guided covered stent optimization vs. Covered stent placement without IVUS guidance was evaluated on Target vessel revascularization (TVR) (OR 0.04, 95% CI 0.02-0.56, p=0.031). IVUS-guided covered stent optimization was associated with a lower risk of target vessel revascularization compared to no IVUS.
Synapse has enriched 10 related papers. Consider them for comparative context: